What does APOTHEEK SEMPELS do?

APOTHEEK SEMPELS is a pharmacy in Grobbendonk. Private Limited, started on 19 April 2002, 1 establishment.

What is the address of APOTHEEK SEMPELS?

The registered office of APOTHEEK SEMPELS is located at Stationlei 2, 2288 Grobbendonk.

Is APOTHEEK SEMPELS still active?

Yes. According to the CBE (30 October 2026) APOTHEEK SEMPELS is active, legal situation “Normale toestand”, started on 19 April 2002.

Is APOTHEEK SEMPELS registered on Peppol?

Yes, APOTHEEK SEMPELS is registered on the Peppol network with ID 0208:0477385795.

What is the enterprise number of APOTHEEK SEMPELS?

The enterprise number of APOTHEEK SEMPELS is BE0477385795.

When was APOTHEEK SEMPELS founded?

APOTHEEK SEMPELS was founded on 19 April 2002.

Who are the directors of APOTHEEK SEMPELS?

According to the 2025 annual accounts, the directors of APOTHEEK SEMPELS are: Steven Sempels.

Is APOTHEEK SEMPELS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 April 2002; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK SEMPELS make in 2025?

APOTHEEK SEMPELS posted a profit after taxes of € 301,462 in financial year 2025.

What is the revenue of APOTHEEK SEMPELS?

As a small company, APOTHEEK SEMPELS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 705,328.

How much does an employee at APOTHEEK SEMPELS earn?

The average wage cost per full-time employee at APOTHEEK SEMPELS was € 54,400 in 2025: staff costs of € 157,717 for 2.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK SEMPELS have?

According to the 2025 annual accounts, APOTHEEK SEMPELS has 2.9 full-time equivalents (FTE).

APOTHEEK SEMPELS (Private Limited) - Grobbendonk

Dossier APOTHEEK SEMPELS, printed on 30 October 2026 from databakkes.be/en/0477385795/apotheek-sempels. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 43 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

APOTHEEK SEMPELS from Grobbendonk, company number BE0477385795, closed financial year 2025 with a result of € 301,462 after tax. For that financial year APOTHEEK SEMPELS recorded a gross margin of € 705,328 and equity of € 963,094. Compared with financial year 2024, the result moved from € 244,815 to € 301,462. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 27, 2026.

What it is worth Healthy

€ 963,094

▼ 33% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 301,462

▲ 23% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 161,866

▼ 48% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 767,748 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

2.9

▼ 0.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 157,717

▼ 14% vs 2024

€ 54,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 71,337

▼ 18% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 93,001

▼ 56% vs 2024

€ 77,733 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 136,388

▼ 26% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 70,759

▲ 98% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 548,113 Gross margin 2021: € 548,113 First fiscal year in the series	€ 751,759 Gross margin 2023: € 751,759 ▲ 37% vs 2021 (€ 548,113) Favourable step	€ 660,608 Gross margin 2024: € 660,608 ▼ 12% vs 2023 (€ 751,759) Unfavourable step	€ 705,328 Gross margin 2025: € 705,328 ▲ 7% vs 2024 (€ 660,608) Favourable step	▲ 7%
Profit after taxes	€ 223,440 Profit after taxes 2021: € 223,440 First fiscal year in the series	€ 333,245 Profit after taxes 2023: € 333,245 ▲ 49% vs 2021 (€ 223,440) Favourable step	€ 244,815 Profit after taxes 2024: € 244,815 ▼ 27% vs 2023 (€ 333,245) Unfavourable step	€ 301,462 Profit after taxes 2025: € 301,462 ▲ 23% vs 2024 (€ 244,815) Favourable step	▲ 23%
Equity	€ 1,097,836 Equity 2021: € 1,097,836 First fiscal year in the series	€ 1,375,913 Equity 2023: € 1,375,913 ▲ 25% vs 2021 (€ 1,097,836) Favourable step	€ 1,429,380 Equity 2024: € 1,429,380 ▲ 4% vs 2023 (€ 1,375,913) Favourable step	€ 963,094 Equity 2025: € 963,094 ▼ 33% vs 2024 (€ 1,429,380) Unfavourable step	▼ 33%
Total debts	€ 854,634 Total debts 2021: € 854,634 First fiscal year in the series	€ 683,397 Total debts 2023: € 683,397 ▼ 20% vs 2021 (€ 854,634) Favourable step	€ 525,558 Total debts 2024: € 525,558 ▼ 23% vs 2023 (€ 683,397) Favourable step	€ 919,763 Total debts 2025: € 919,763 ▲ 75% vs 2024 (€ 525,558) Unfavourable step	▲ 75%
Cash	€ 206,278 Cash 2021: € 206,278 First fiscal year in the series	€ 214,652 Cash 2023: € 214,652 ▲ 4% vs 2021 (€ 206,278) Favourable step	€ 309,478 Cash 2024: € 309,478 ▲ 44% vs 2023 (€ 214,652) Favourable step	€ 161,866 Cash 2025: € 161,866 ▼ 48% vs 2024 (€ 309,478) Unfavourable step	▼ 48%
Land & buildings	€ 210,816 Land & buildings 2021: € 210,816 First fiscal year in the series	€ 195,814 Land & buildings 2023: € 195,814 ▼ 7% vs 2021 (€ 210,816) Unchanged	€ 195,814 Land & buildings 2024: € 195,814 Unchanged (€ 195,814) Unchanged	€ 195,814 Land & buildings 2025: € 195,814 Unchanged (€ 195,814) Unchanged
Retained profit	€ 1,077,836 Retained profit 2021: € 1,077,836 First fiscal year in the series	€ 1,355,913 Retained profit 2023: € 1,355,913 ▲ 26% vs 2021 (€ 1,077,836) Favourable step	€ 1,409,380 Retained profit 2024: € 1,409,380 ▲ 4% vs 2023 (€ 1,355,913) Favourable step	€ 943,094 Retained profit 2025: € 943,094 ▼ 33% vs 2024 (€ 1,409,380) Unfavourable step	▼ 33%
Dividend	€ 184,428 Dividend 2021: € 184,428 First fiscal year in the series	€ 154,913 Dividend 2023: € 154,913 ▼ 16% vs 2021 (€ 184,428) Unchanged	€ 191,347 Dividend 2024: € 191,347 ▲ 24% vs 2023 (€ 154,913) Unchanged	€ 767,748 Dividend 2025: € 767,748 ▲ € 576,400 vs 2024 (€ 191,347) Unchanged	▲ € 576,400
Bank debt	€ 461,546 Bank debt 2021: € 461,546 First fiscal year in the series	€ 328,326 Bank debt 2023: € 328,326 ▼ 29% vs 2021 (€ 461,546) Favourable step	€ 211,190 Bank debt 2024: € 211,190 ▼ 36% vs 2023 (€ 328,326) Favourable step	€ 93,001 Bank debt 2025: € 93,001 ▼ 56% vs 2024 (€ 211,190) Favourable step	▼ 56%
Balance sheet total	€ 1,952,470 Balance sheet total 2021: € 1,952,470 First fiscal year in the series	€ 2,059,310 Balance sheet total 2023: € 2,059,310 ▲ 5% vs 2021 (€ 1,952,470) Unchanged	€ 1,954,939 Balance sheet total 2024: € 1,954,939 ▼ 5% vs 2023 (€ 2,059,310) Unchanged	€ 1,882,857 Balance sheet total 2025: € 1,882,857 ▼ 4% vs 2024 (€ 1,954,939) Unchanged	▼ 4%
Employees (FTE)	2.8 Employees (FTE) 2021: 2.8 First fiscal year in the series	3.2 Employees (FTE) 2023: 3.2 ▲ 0.4 vs 2021 (2.8) Unchanged	3.2 Employees (FTE) 2024: 3.2 Unchanged (3.2) Unchanged	2.9 Employees (FTE) 2025: 2.9 ▼ 0.3 vs 2024 (3.2) Unchanged	▼ 0.3

Key figures of APOTHEEK SEMPELS, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to APOTHEEK SEMPELS?

What happened at APOTHEEK SEMPELS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 27, 2026 New annual accounts for financial year 2025: profit of € 301,462 (▲ 23% vs 2024). Source: NBB ↗
May 23, 2002 New establishment in Grobbendonk. KBO
Apr 19, 2002 Start of the company according to the CBE. KBO
2002 Steven Sempels became a director. NBB

In short

From € 223,440 profit in 2021 to € 301,462 profit in 2025.

Paid € 460,117 in corporate taxes since 2021.

Best year ever: 2023, with € 333,245 profit.

On average € 243,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Steven Sempels

APOTHEEK SEMPELS

Behind APOTHEEK SEMPELS is Steven Sempels.

Directors

According to the 2025 annual accounts

Steven Sempels

Director

since 2002

Establishments

Establishment units

Physical locations of this company

Registered office

Stationlei 2

2288 Grobbendonk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0477.385.795

VAT number

BE 0477.385.795

Registered office

Stationlei 2, 2288 Grobbendonk

Names & denominations

APOTHEEK SEMPELS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

19 April 2002

Peppol

Active · Active since 26 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Activiteiten van holdings

Managementactiviteiten van holdings

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK SEMPELS

Warning lights

Financials

What happened to APOTHEEK SEMPELS?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions